Florbetapir F18, Florbetaben F 18, Ly4560736
Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid, Plasma
Phase I
Not Yet Recruiting
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
Sep 22, 2026
―
Combined Oral Contraceptive, Eloralintide, Ly3841136
Obesity, Overweight
Phase I
Recruiting
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Sep 03, 2026
―
Orforglipron, Ly3502970
Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal
Phase III
Recruiting
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Aug 26, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly & Co (LLY) have in its pipeline
LLY is currently developing the following drugs: Florbetapir F18, Florbetaben F 18, Ly4560736, Vepugratinib, Ly3866288, Selpercatinib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.